UPClytics
View all cases

UPC CoA 405/2024

Jul 11, 2024·EP3167888 Unitary patent · TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT

Case details
Status
Case Closed
Action
Appeal
Category
Main appeal
Parties
Claimants
Representatives
Respondents
Representatives
Division
Court of Appeal
Technology
  • Chemistry
    Biotechnology · Pharmaceuticals
Language
English
First decided
Jul 30, 2024
Last decision
Jun 19, 2025
EPO Opposition
How this compares
How long the court takes to reach a first decision.
Median days to first decision
All UPC124
Judge Rian KaldenLocked
Judge Patricia RombachLocked
Judge Ingeborg SimonssonLocked

At the UPC: AstraZeneca Group (13 cases)·Amgen Group (19 cases)

This dispute contains 2 other proceedings

UPC APP 43687/2024·UPC CFI 124/2024

6 other defendants litigating the same or a related patent

UPC CoA 744/2025·UPC CFI 674/2025·UPC CFI 51/2025·UPC CFI 642/2024·UPC CoA 402/2024 and 1 more

Start a free trial to see how each one ended.

More cases: Court of Appeal·2024

Decisions
  • 2025-06-19

    Summary: The Court of Appeal set out general principles for rehearing applications under Art. 81(1)(b) UPCA, establishing that only fundamental procedural defects that would have led to a different outcome can justify rehearing, in proceedings where Alexion sought to reopen a dismissed provisional measures appeal against Amgen concerning EP 3 167 888.

    Show the legal issues (3)
    • Rehearing application (Art. 81(1) UPCA, R. 245 RoP)
    • Fundamental procedural defect
    • Standard for reopening final decisions
  • 2024-12-20
    Appeal RoP220.1Public

    Summary: The Court of Appeal dismissed Alexion's appeal against the first-instance refusal of provisional measures, upholding the finding that the patent claim could not be corrected by interpretation to remove alleged errors, and confirming that claim 2 of EP 3 167 888 was more likely than not insufficiently disclosed (Article 83 EPC). The provisional measures application was therefore denied.

    Show the legal issues (5)
    • Claim interpretation — correction of errors
    • Insufficiency of disclosure (Article 83 EPC)
    • Provisional measures
    • Claim interpretation from perspective of skilled person
    • Patent prosecution history (TBA proceedings)
  • 2024-08-08

    Summary: The Court of Appeal ruled that service of written pleadings must be effected through the Court's electronic CMS and that prior communication via Germany's beA (besonderes elektronisches Anwaltspostfach) does not constitute effective service under R.278.1 RoP.

    Show the legal issues (4)
    • Service of documents
    • R.278.1 RoP
    • Electronic CMS service
    • beA (besonderes elektronisches Anwaltspostfach)
  • 2024-07-30

    Summary: The Court of Appeal rejected Alexion Pharmaceuticals' request to expedite the appeal against the Hamburg Local Division's refusal to grant provisional measures against Amgen, holding that the circumstances were not sufficiently urgent to justify shortening the time period for the respondents to lodge their statement of response.

    Show the legal issues (5)
    • Expedition of appeal
    • R.9.3(b) RoP
    • Shortening of deadlines
    • Provisional measures appeal
    • R.225(e) RoP
Documents
Document titleDatePublic
Cover sheet2025-11-25Not public
Other document Appellant2025-11-25Not public
Receipt2025-11-25Not public
20250721_Confidentiality_Request_re_Application_cost_decision_rehearing2025-07-21Not public
20250721_Confidentiality_Request_re_Application_cost_decision_rehearing2025-07-21Not public
20250721_Application_cost_decision_rehearing_Confidential2025-07-21Not public
Headnote-and-Keywords2025-06-19Not public
Outcome of the Order2025-06-19Not public
Decision2025-06-19Public
Exhibit_BP_33_Amgen_en2025-05-12Not public
Exhibit_BP_31_Amgen_en2025-05-12Not public
Reply_to_Application_for Rehearing_Amgen_en.pdf_signed2025-05-12Not public
Exhibit_BP_32_Amgen_en2025-05-12Not public
Reply_to_Application_for Rehearing_Amgen_en.pdf_signed2025-05-12Not public
Exhibit_BP_33_Amgen_en2025-05-12Not public
Exhibit_BP_32_Amgen_en2025-05-12Not public
Exhibit_BP_31_Amgen_en2025-05-12Not public
Reply_to_Application_for Rehearing_Amgen_en.pdf_signed2025-05-12Not public
Exhibit_BP_33_Amgen_en2025-05-12Not public
Exhibit_BP_31_Amgen_en2025-05-12Not public
Exhibit_BP_32_Amgen_en2025-05-12Not public
Reply_to_Application_for Rehearing_Amgen_en.pdf_signed2025-05-12Not public
Exhibit_BP_31_Amgen_en2025-05-12Not public
Exhibit_BP_33_Amgen_en2025-05-12Not public
Exhibit_BP_32_Amgen_en2025-05-12Not public
Reply_to_Application_for Rehearing_Amgen_en.pdf_signed2025-05-12Not public
Exhibit_BP_31_Amgen_en2025-05-12Not public
Exhibit_BP_33_Amgen_en2025-05-12Not public
Exhibit_BP_32_Amgen_en2025-05-12Not public
Exhibit_BP_32_Amgen_en2025-05-12Not public
Exhibit_BP_31_Amgen_en2025-05-12Not public
Exhibit_BP_33_Amgen_en2025-05-12Not public
Reply_to_Application_for Rehearing_Amgen_en.pdf_signed2025-05-12Not public
Exhibit_BP_32_Amgen_en2025-05-12Not public
Exhibit_BP_33_Amgen_en2025-05-12Not public
Reply_to_Application_for Rehearing_Amgen_en.pdf_signed2025-05-12Not public
Exhibit_BP_31_Amgen_en2025-05-12Not public
Exhibit_BP_33_Amgen_en2025-05-12Not public
Exhibit_BP_32_Amgen_en2025-05-12Not public
Exhibit_BP_31_Amgen_en2025-05-12Not public
Reply_to_Application_for Rehearing_Amgen_en.pdf_signed2025-05-12Not public
Exhibit_BP_31_Amgen_en2025-05-12Not public
Exhibit_BP_32_Amgen_en2025-05-12Not public
Exhibit_BP_33_Amgen_en2025-05-12Not public
Reply_to_Application_for Rehearing_Amgen_en.pdf_signed2025-05-12Not public
Outcome of the Order2025-05-08Not public
Order access to recording of oral hearing2025-05-08Public
Receipt2025-05-06Not public
Request for the recording of the oral hearing to be made available2025-05-06Not public
Outcome of the Order2025-04-08Not public
Order on access to recording of oral hearing2025-04-08Public
Receipt2025-04-07Not public
20250404_Request_Recording_oral_hearing_Amgen2025-04-04Not public
Headnote-and-Keywords2025-03-18Not public
request comments2025-03-11Not public
Panel-Appointment2025-03-06Not public
Receipt2025-03-06Not public
25-02-20_-_EP_888_-_Alexion_vs_Amgen_-_Rehearing_request2025-02-20Not public
Exhibit FBD 692025-02-20Not public
Exhibit FBD 722025-02-20Not public
Exhibit FBD 702025-02-20Not public
Exhibit FBD 732025-02-20Not public
Exhibit FBD 712025-02-20Not public
Final order Alexion / Amgen - anonymized2024-12-23Not public
Acknowledgement-of-lodging2024-12-20Not public
Decision-On-Appeal-On-Measures-Outcome2024-12-20Not public
Final order2024-12-20Not public
Final order2024-12-20Public
Hearing reference2024-11-07Not public
Hearing reference2024-11-07Not public
Outcome of the Order2024-10-17Not public
Procedural order2024-10-17Public
Exhibit FBD 38a2024-10-14Not public
Response to order2024-10-14Not public
Statement_re_application_for_review_procedural_order2024-10-11Not public
Statement_re_application_for_review_procedural_order2024-10-11Not public
Statement_re_application_for_review_procedural_order2024-10-11Not public
Statement_re_application_for_review_procedural_order2024-10-11Not public
Statement_re_application_for_review_procedural_order2024-10-11Not public
Statement_re_application_for_review_procedural_order2024-10-11Not public
Statement_re_application_for_review_procedural_order2024-10-11Not public
Statement_re_application_for_review_procedural_order2024-10-11Not public
Statement_re_application_for_review_procedural_order2024-10-11Not public
Procedural order2024-10-09Public
Procedural order2024-10-04Not public
Acknowledgement-of-lodging2024-10-03Not public
Exhibit 692024-10-02Not public
24-10-02_-_EP_888_-_Alexion_vs_Amgen_-_R_333_application_on_oral_hearing_order-signed2024-10-02Not public
Panel-Appointment2024-09-17Not public
interimProcedureClosure2024-09-17Not public
summons2024-09-17Not public
Procedural order2024-09-17Public
Procedural order2024-09-17Public
Comments2024-09-12Not public
Preliminary order2024-09-04Not public
interimConferenceDecisionAppeal2024-09-04Not public
Panel-Appointment2024-08-30Not public
Receipt2024-08-14Not public
Application2024-08-13Not public
Acknowledgement-of-lodging2024-08-13Not public
Statement of response2024-08-13Not public
BP 302024-08-13Not public
Statement of response2024-08-13Not public
Acknowledgement-of-lodging2024-08-13Not public
BP 302024-08-13Not public
Statement of response2024-08-13Not public
Statement of response2024-08-13Not public
Acknowledgement-of-lodging2024-08-13Not public
Statement of response2024-08-13Not public
BP 302024-08-13Not public
Statement of response2024-08-13Not public
Acknowledgement-of-lodging2024-08-13Not public
Statement of response2024-08-13Not public
Statement of response2024-08-13Not public
BP 302024-08-13Not public
Acknowledgement-of-lodging2024-08-13Not public
Statement of response2024-08-13Not public
BP 302024-08-13Not public
Statement of response2024-08-13Not public
Acknowledgement-of-lodging2024-08-13Not public
Statement of response2024-08-13Not public
BP 302024-08-13Not public
Statement of response2024-08-13Not public
Acknowledgement-of-lodging2024-08-13Not public
Statement of response2024-08-13Not public
BP 302024-08-13Not public
Statement of response2024-08-13Not public
Acknowledgement-of-lodging2024-08-13Not public
Statement of response2024-08-13Not public
BP 302024-08-13Not public
Statement of response2024-08-13Not public
Acknowledgement-of-lodging2024-08-13Not public
BP 302024-08-13Not public
Statement of response2024-08-13Not public
Statement of response2024-08-13Not public
Outcome of the Order2024-08-08Not public
Order of 8 August 20242024-08-08Public
Comments2024-08-02Not public
Preliminary order of 1August 20242024-08-01Not public
Receipt2024-07-31Not public
Application2024-07-31Not public
Outcome of the Order2024-07-30Not public
Order of 30 July 20242024-07-30Public
Acknowledgement-of-lodging2024-07-30Not public
Receipt2024-07-29Not public
Grounds of appeal2024-07-27Not public
Procedural order2024-07-26Public
20240723_Response_Amgen_request_sub_VII2024-07-23Not public
20240723_Response_Amgen_request_sub_VII2024-07-23Not public
20240723_Response_Amgen_request_sub_VII2024-07-23Not public
20240723_Response_Amgen_request_sub_VII2024-07-23Not public
20240723_Response_Amgen_request_sub_VII2024-07-23Not public
20240723_Response_Amgen_request_sub_VII2024-07-23Not public
20240723_Response_Amgen_request_sub_VII2024-07-23Not public
20240723_Response_Amgen_request_sub_VII2024-07-23Not public
20240723_Response_Amgen_request_sub_VII2024-07-23Not public
Preliminary order2024-07-22Not public
Panel-Appointment2024-07-22Not public
Receipt2024-07-22Not public
Formal-checks_Notification-of-positive-outcome2024-07-22Not public
Acknowledgement-of-lodging2024-07-11Not public
Exhibit FBD 682024-07-11Not public
Appeal2024-07-11Not public